Pierce A - Search Results

1

Quantitative SWATH-based proteomic profiling of urine for the identification of endometrial cancer biomarkers in symptomatic women.

Njoku K, Pierce A, Geary B, Campbell AE, Kelsall J, Reed R, Armit A, Da Sylva R, Zhang L, Agnew H, Baricevic-Jones I, Chiasserini D, Whetton AD, Crosbie EJ. Njoku K, et al. Among authors: pierce a. Br J Cancer. 2023 May;128(9):1723-1732. doi: 10.1038/s41416-022-02139-0. Epub 2023 Feb 17. Br J Cancer. 2023. PMID: 36807337 Free PMC article.

2

Macrophage inflammatory protein-1 alpha receptors are present on cells enriched for CD34 expression from patients with chronic myeloid leukemia.

Chasty RC, Lucas GS, Owen-Lynch PJ, Pierce A, Whetton AD. Chasty RC, et al. Among authors: pierce a. Blood. 1995 Dec 1;86(11):4270-7. Blood. 1995. PMID: 7492787 Free article.

3

Haemopoietic growth factors and leukaemogenesis.

Pierce A, Whetton AD. Pierce A, et al. Biochem Soc Trans. 1997 May;25(2):366-70. doi: 10.1042/bst0250366. Biochem Soc Trans. 1997. PMID: 9191119 Review. No abstract available.

4

Transforming growth factor-beta 1 induces apoptosis independently of p53 and selectively reduces expression of Bcl-2 in multipotent hematopoietic cells.

Francis JM, Heyworth CM, Spooncer E, Pierce A, Dexter TM, Whetton AD. Francis JM, et al. Among authors: pierce a. J Biol Chem. 2000 Dec 15;275(50):39137-45. doi: 10.1074/jbc.M007212200. J Biol Chem. 2000. PMID: 10993901 Free article.

5

The specific enhancement of interferon alpha induced growth inhibition by BCR/ABL only occurs in multipotent cells.

Pierce A, Smith DL, Jakobsen LV, Whetton AD, Spooncer E. Pierce A, et al. Hematol J. 2001;2(4):257-64. doi: 10.1038/sj.thj.6200114. Hematol J. 2001. PMID: 11920258

6

BCR-ABL alters the proliferation and differentiation response of multipotent hematopoietic cells to stem cell factor.

Pierce A, Spooncer E, Ainsworth S, Whetton AD. Pierce A, et al. Oncogene. 2002 May 2;21(19):3068-75. doi: 10.1038/sj.onc.1205424. Oncogene. 2002. PMID: 12082538

7

Identification of primary structural features that define the differential actions of IL-3 and GM-CSF receptors.

Evans CA, Ariffin S, Pierce A, Whetton AD. Evans CA, et al. Among authors: pierce a. Blood. 2002 Nov 1;100(9):3164-74. doi: 10.1182/blood-2001-12-0235. Blood. 2002. PMID: 12384414 Free article.

8

Changes in the proteome associated with the action of Bcr-Abl tyrosine kinase are not related to transcriptional regulation.

Smith DL, Evans CA, Pierce A, Gaskell SJ, Whetton AD. Smith DL, et al. Among authors: pierce a. Mol Cell Proteomics. 2002 Nov;1(11):876-84. doi: 10.1074/mcp.m200035-mcp200. Mol Cell Proteomics. 2002. PMID: 12488463 Free article.

9

Lysophospholipids synergistically promote primitive hematopoietic cell chemotaxis via a mechanism involving Vav 1.

Whetton AD, Lu Y, Pierce A, Carney L, Spooncer E. Whetton AD, et al. Among authors: pierce a. Blood. 2003 Oct 15;102(8):2798-802. doi: 10.1182/blood-2002-12-3635. Epub 2003 Jun 26. Blood. 2003. PMID: 12829605 Free article.

10

Generation of a conditionally immortalized myeloid progenitor cell line requiring the presence of both interleukin-3 and stem cell factor to survive and proliferate.

Lee C, Evans CA, Spooncer E, Pierce A, Mottram R, Whetton AD. Lee C, et al. Among authors: pierce a. Br J Haematol. 2003 Sep;122(6):985-95. doi: 10.1046/j.1365-2141.2003.04537.x. Br J Haematol. 2003. PMID: 12956770 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

924 results

Search Page

Filters